Censi Simona, Cavedon Elisabetta, Bertazza Loris, Galuppini Francesca, Watutantrige-Fernando Sara, De Lazzari Paola, Nacamulli Davide, Pennelli Gianmaria, Fassina Ambrogio, Iacobone Maurizio, Casal Ide Eric, Vianello Federica, Barollo Susi, Mian Caterina
Endocrinology Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Surgical Pathology and Cytopathology Unit, Pathology Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Front Endocrinol (Lausanne). 2017 Oct 16;8:273. doi: 10.3389/fendo.2017.00273. eCollection 2017.
The management of thyroid nodules of indeterminate cytology is controversial. Our study aimed to establish the frequency and significance of promoter, and gene mutations in thyroid nodes of indeterminate cytology and to assess their potential usefulness in clinical practice.
-,-, promoter and gene mutations were examined in a series of 199 consecutive nodes of indeterminate cytology referred for surgical excision.
69/199 (35%) were malignant on histopathological review. mutations were detected in 36/199 (18%), and 19/36 cases (53%) were malignant on histological diagnosis. promoter mutations were detected in 7/199 (4%) nodules, which were all malignant lesions. mutations were detected in 15/199 (8%), and a K601E mutation was identified in 2 follicular adenomas and 1 noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Altogether, this panel was able to identify 48% of the malignant lesions, achieving a specificity, positive predictive value, and negative predictive value for malignancy of 85, 62, and 75%, respectively.
The residual malignancy risk in mutation-negative nodes is 25%. These nodes still need to be resected, but mutation analysis could help to orient the appropriate surgical strategy.
甲状腺细针穿刺活检结果不确定的甲状腺结节的管理存在争议。我们的研究旨在确定甲状腺细针穿刺活检结果不确定的甲状腺结节中启动子和基因的突变频率及意义,并评估它们在临床实践中的潜在用途。
对一系列199个连续的甲状腺细针穿刺活检结果不确定且接受手术切除的结节进行了-、-、启动子和基因的突变检测。
组织病理学检查显示,199个结节中有69个(35%)为恶性。199个结节中有36个(18%)检测到突变,其中19例(53%)经组织学诊断为恶性。199个结节中有7个(4%)检测到启动子突变,均为恶性病变。199个结节中有15个(8%)检测到突变,在2个滤泡性腺瘤和1个具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤中鉴定出K601E突变。总体而言,该检测能够识别48%的恶性病变,对恶性肿瘤的特异性、阳性预测值和阴性预测值分别为85%、62%和75%。
突变阴性结节的残余恶性风险为25%。这些结节仍需切除,但突变分析有助于确定合适的手术策略。